IHS Chemical Week

World News and Views :: Top of the News

Shasun Ties with Merck & Co.

7:45 AM MST | February 27, 2008 |

Deepti Ramesh

Shasun Chemicals & Drugs (Chennai, India), a pharmaceutical company, says it has entered into an active pharma ingredient (API) technology licensing agreement with Merck & Co. Inc. (Whitehouse Station, NJ). Under the non-exclusive agreement, Shasun will provide Merck with the use of its proprietary cross-coupling copper technology (known as Buchwald technology) to manufacture and commercialize APIs.  “This is an important milestone for Shasun in making this technology widely accessible and paving the way for further collaborations,” says...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa